The DOI matches its Crossref record; 69 of the 74 references it cites were found in a registry or an index.
Cancer in dyskeratosis congenita
Open accessAbstract
Dyskeratosis congenita (DC) is a rare inherited bone marrow failure syndrome. The spectrum of cancer susceptibility in this disorder of telomere biology has not been described. There were more than 500 cases of DC reported in the literature from 1910 to 2008; the National Cancer Institute (NCI) prospective DC cohort enrolled 50 cases from 2002 to 2007. Sixty cancers were reported in 52 literature cases, while 7 occurred among patients in the NCI DC cohort. The 2 cohorts were comparable in their median overall survival (42 years) and cumulative incidence of cancer (40%-50% by age 50 years). The most frequent solid tumors were head and neck squamous cell carcinomas (40% of patients in either cohort), followed by skin and anorectal cancer. The ratio of observed to expected cancers (O/E ratio) in the NCI cohort was 11-fold compared with the general population (P < .05). Significantly elevated O/E ratios were 1154 for tongue cancer and 195 for acute myeloid leukemia. Survival after bone marrow transplantation for aplastic anemia or leukemia was poor in both cohorts. The frequency and types of cancer in DC are surpassed only by those in Fanconi anemia (FA), indicating that FA and DC have similarly high risks of adverse hematologic and neoplastic events, and patients with these diseases should be counseled and monitored similarly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, both dyskeratosis congenita and IPF patients are prone to developing haematological malignancies, commonly manifesting as myelodysplasia or acute myeloid leukaemia70,75,76.”
From The telomere syndromes (2012) · cites this paper as [75]
In the citing paper
“In classic dyskeratosis congenita, where it has been studied, cancer diagnoses have been estimated to occur at an 11-fold increased incidence relative to the population in one series75.”
From The telomere syndromes (2012) · cites this paper as [75]
In the citing paper
“The cancer spectrum in dyskeratosis congenita has a predilection for high-turnover tissues with an increased incidence of squamous cell carcinomas of the skin, upper aerodigestive and anogenital tracts75.”
From The telomere syndromes (2012) · cites this paper as [75]
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P. J., & Dokal, I. (2001) · Nature · doi:10.1038/35096585 · Cited by 960 · cited 3×
“Median age at death, y (range) 21 (2-70) 17 (2-68) 29 (19-70) .”
Dyskeratosis congenita in all its forms
Dokal, I. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02109.x · Cited by 575
Cancer incidence in persons with Fanconi anemia
Rosenberg, P. S., Greene, M. H., & Alter, B. P. (2003) · Blood · doi:10.1182/blood-2002-05-1498 · Cited by 520
Self-citationCancer in Fanconi anemia, 1927–2001
Alter, B. P. (2003) · Cancer · doi:10.1002/cncr.11046 · Cited by 432
Self-citationRosenberg, P. S. (2006) · Blood · doi:10.1182/blood-2005-11-4370 · Cited by 431
Self-citationSavage, S. A., Giri, N., Baerlocher, G. M., Orr, N., Lansdorp, P. M., & Alter, B. P. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.10.004 · Cited by 414
Self-citationAlter, B. P., Baerlocher, G. M., Savage, S. A., Chanock, S. J., Weksler, B. B., Willner, J. P., Peters, J. A., Giri, N., & Lansdorp, P. M. (2007) · Blood · doi:10.1182/blood-2007-02-075598 · Cited by 356
Self-citationVulliamy, T. J., Marrone, A., Knight, S. W., Walne, A., Mason, P. J., & Dokal, I. (2006) · Blood · doi:10.1182/blood-2005-07-2622 · Cited by 345
Research works printed but not linked: 10
- StataCorp, 2007, Stata Statistical Software: Release 10
- MATLAB, 2008, The language of technical computing
- Kubicz, 1970, Syndroma Zinsser-Engman-Cole cum dyschromia extensiva corporis., Przegl Derm, 57, 239
- Camacho, 1982, Sindrome de Zinsser-Cole-Engman: Disqueratosis congenita., Med Cut ILA, 10, 365
- Schmidt, 1983, Zinsser-Engman-Cole-Syndrom., Der Hautarzt, 34, 286
- Lespinasse, 1988, Dyskeratose congenitale ou dyskeratose de Zinsser-Cole-Engman: un cas feminin probable., Presse Med, 17, 1047
- Costello, 1957, Dyskeratosis congenita with superimposed prickle-cell epithelioma on the dorsal aspect of the left hand., Arch Dermatol, 75, 451
- Orfanos, 1966, Leukoplakien, Pigmentverschiebungen und Nageldystrophie. Zinsser-Cole-Engman-Syndrom-sog. Dyskeratosis congenita., Med Welt, 48, 2589
- Skvortsova, 2003, Clinicohematological manifestations of congenital dyskeratosis: presentation of three clinical cases., Gematol Transfuziol, 48, 13
- 2003, Fanconi Anemia: Standards for Clinical Care
Cited by
Armanios, M., & Blackburn, E. H. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3246 · Cited by 982
Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges
Shallis, R. M., Wang, R., Davidoff, A., Ma, X., & Zeidan, A. M. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.04.005 · Cited by 941
Ribosomopathies: human disorders of ribosome dysfunction
Narla, A., & Ebert, B. L. (2010) · Blood · doi:10.1182/blood-2009-10-178129 · Cited by 809
Calado, R. T., & Young, N. S. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0903373 · Cited by 754
The association of telomere length and cancer: a meta-analysis
Wentzensen, I. M., Mirabello, L., Pfeiffer, R. M., & Savage, S. A. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0005 · Cited by 458
Self-citation
Metadata
- Authors
- Alter, B. P., Giri, N., Savage, S. A., & Rosenberg, P. S.
- Affiliations
- Clinical Genetics Branch and
- National Institutes of Health (US)
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2009-06-25
- Volume
- 113
- Issue
- 26
- Pages
- 6549-6557
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC2710915
- OpenAlex
- W2034022379
- Cited by
- 478
- References
- 74
- Citations by year
- 2026: 15 · 2025: 14 · 2024: 25 · 2023: 15 · 2022: 27 · 2021: 34 · 2020: 34 · 2019: 27 · 2018: 33 · 2017: 33 · 2016: 26 · 2015: 31 · 2014: 29 · 2013: 34 · 2012: 23
- FWCI
- 3.18
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Blood (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- dyskeratosis congenita, cancer susceptibility, telomere biology, bone marrow failure syndromes, head and neck squamous cell carcinoma, tongue cancer, acute myeloid leukemia, aplastic anemia, skin cancer, anorectal cancer, Fanconi anemia, bone marrow transplantation, survival, cancer incidence
- MeSH terms
- Acute Disease, Adolescent, Adult, Aged, Anemia, Aplastic, Child, Child, Preschool, Female, Humans, Infant, Male, Middle Aged, Neoplasms, Neoplasms, Multiple Primary, Neoplastic Syndromes, Hereditary, Risk, Cohort Studies, Comorbidity, Incidence, Survival Analysis, Bone Marrow Transplantation, Telomere, Age of Onset, Dyskeratosis Congenita, Genetic Predisposition to Disease, Kaplan-Meier Estimate, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cancer in dyskeratosis congenita. https://app.cochat.ai/papers/10.1182/blood-2008-12-192880
- The paper
- Alter, B. P., Giri, N., Savage, S. A., & Rosenberg, P. S. (2009). Cancer in dyskeratosis congenita. Blood. https://doi.org/10.1182/blood-2008-12-192880
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.